Novo Nordisk A/S is likely to account for about half of Denmark’s economic expansion this year, helping the nation to outperform its Nordic neighbors, according to the country’s largest bank.
Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1 ...